☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Conditional Marketing Authorisation
Celltrion's Regdanvimab (CT-P59) Receives Korean MFDS Conditional Marketing Authorization for COVID-19
February 8, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.